Biogen, Inc. (BIIB)
191.29
-13.24
(-6.47%)
USD |
NASDAQ |
May 14, 16:00
192.60
+1.31
(+0.68%)
After-Hours: 20:00
Biogen Shareholders Equity (Quarterly) : 18.65B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Gilead Sciences, Inc. | 23.52B |
| AbbVie, Inc. | -6.656B |
| Apellis Pharmaceuticals, Inc. | 414.92M |
| Moderna, Inc. | 7.408B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.48B |
| Total Liabilities (Quarterly) | 10.83B |
| Debt to Equity Ratio | 0.3518 |
| Current Ratio | 3.065 |
| Net Debt Paydown Yield | 0.11% |